ClinicalTrials.Veeva

Menu

Smart Boot Use to Measure Offloading Adherence

University of Southern California logo

University of Southern California

Status and phase

Enrolling
Phase 2

Conditions

Diabetic Foot Ulcer

Treatments

Device: Offloading Boot

Study type

Interventional

Funder types

Other

Identifiers

NCT04460573
HS-20-00526

Details and patient eligibility

About

The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their foot heal. Sometimes people don't wear the boot like they are told. The investigators want to compare three different kinds of diabetic boots to see if they can help make it easier for people to wear their boots as instructed.

The investigators will look at three groups of participants: the first group will use removable offloading with reinforced education emphasizing continuous wear, including during rest and sleep, and not to remove it at any time. The second group will use removable offloading consistent with standard of care and receive education on recommended wear during walking or standing, with permission to remove the device during rest and sleep. The third group will use a smart removable offloading device that provides real-time adherence feedback via a smartwatch and smartphone, with additional personalized education informed by remotely monitored adherence data.

The investigators will also be looking at how much physical activity, like walking, the participants do. And they will compare how well participants sleep and rate their quality of life in the three different boots. The investigators think that giving participants information about how much they are wearing their boot using readily available technology will help them to follow the doctor's directions better, and help their wounds heal faster.

Enrollment

210 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female
  • ≥18 years old
  • Non-infected, non-ischemic DFU requiring offloading
  • Ambulatory at home with or without assistance
  • Willing and able to provide written informed consent

Exclusion criteria

  • Wound present for > 1 year
  • HbA1c > 12%
  • ABI of index limb < 0.6 or non-detectable Doppler, and/or patient being considered for revascularization during the course of the study
  • Acute Charcot neuropathy or a major foot deformity that doesn't allow them to wear the smart boot
  • Amputation proximal to the rearfoot on the affected extremity
  • Any clinically significant medical or psychiatric condition
  • Laboratory abnormality that would interfere with the ability to participate in the study
  • Concurrently participating in exercise training
  • Changes in psychotropic or sleep medication in the last 6 weeks
  • Ulcer involves bone
  • Ulcer not of diabetic origin
  • Unable or unwilling to attend prescribed clinic visits or comply with protocol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

210 participants in 3 patient groups

Group 1: Reference Group
Active Comparator group
Description:
The group 1 will receive above-standard of care intervention, which includes wearing a standard removable boot and enhanced eductaion with weekly adherence reinforcement. In this group, participants are interviewed weekly, adherence is reviewed, and education is reinforced at each visit. Participants are instructed to wear the offloading device at all times, including during rest and at night, and not to remove it at any time.
Treatment:
Device: Offloading Boot
Group 2: Control Group
Active Comparator group
Description:
The control group uses removable offloading and represents the standard of care. These participants receive education at baseline and are advised to wear the offloading device during walking or standing; however, they are allowed to remove it during rest and sleep.
Treatment:
Device: Offloading Boot
Group 3: SmartBoot
Experimental group
Description:
The SmartBoot group follows a similar protocol to the control group, but adherence to wearing offloading during weight-bearing activities is reinforced using a smartwatch. The smartwatch provides real-time reminders when participants walk without the offloading device. In addition, data from remote patient monitoring may help personalize education during weekly clinic visits conducted by the research coordinator.
Treatment:
Device: Offloading Boot

Trial contacts and locations

4

Loading...

Central trial contact

Bijan Najafi, PHD; Fabiola Rodriguez, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems